Kolltan's mission is to develop novel therapeutics targeting proprietary discoveries in the mechanisms of receptor tyrosine kinase activation.




The company will strive to benefit patients, partners, employees and shareholders.




We value meaningful clinical impact, excellence, intensity of effort, fair dealing, and commercial success.